U.S. Biopsy Devices Market Size & Outlook, 2023-2030

The biopsy devices market in the United States is expected to reach a projected revenue of US$ 1,068.0 million by 2030. A compound annual growth rate of 4.6% is expected of the United States biopsy devices market from 2024 to 2030.
Revenue, 2023 (US$M)
$780.0
Forecast, 2030 (US$M)
$1,068.0
CAGR, 2024 - 2030
4.6%
Report Coverage
U.S.

U.S. biopsy devices market highlights

  • The U.S. biopsy devices market generated a revenue of USD 780.0 million in 2023 and is expected to reach USD 1,068.0 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 4.6% from 2024 to 2030.
  • In terms of segment, needle-based biopsy guns was the largest revenue generating product in 2023.
  • Needle-based Biopsy Guns is the most lucrative product segment registering the fastest growth during the forecast period.

Biopsy devices market data book summary

Market revenue in 2023USD 780.0 million
Market revenue in 2030USD 1,068.0 million
Growth rate4.6% (CAGR from 2023 to 2030)
Largest segmentNeedle-based biopsy guns
Fastest growing segmentNeedle-based Biopsy Guns
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationNeedle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps
Key market players worldwideCardinal Health Inc, Hologic Inc, Danaher Corp, Conmed Corp, Cook Medical, Inrad Optics Inc, TransMedics Group Inc, DTR Medical, Gallia County Health Department

Other key industry trends

  • In terms of revenue, U.S. accounted for 34.6% of the global biopsy devices market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. biopsy devices market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 331.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biopsy Devices Market Companies

Name Profile # Employees HQ Website

U.S. biopsy devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopsy devices market will help companies and investors design strategic landscapes.


Needle-based biopsy guns was the largest segment with a revenue share of 50.49% in 2023. Horizon Databook has segmented the U.S. biopsy devices market based on needle-based biopsy guns, biopsy guidance systems, biopsy needles, biopsy forceps covering the revenue growth of each sub-segment from 2018 to 2030.


  • U.S. Biopsy Devices Product Outlook (Revenue, USD Million, 2018-2030)
    • Needle-based Biopsy Guns
      • Vacuum-assisted Biopsy (VAB) Devices
      • Fine Needle Aspiration Biopsy (FNAB) Devices
      • Core Needle Biopsy (CNB) devices
    • Biopsy Guidance Systems
      • Manual
      • Robotic
    • Biopsy Needles
      • Disposable
      • Reusable
    • Biopsy Forceps
      • General Biopsy Forceps
      • Hot Biopsy Forceps
    • Others
      • Brushes
      • Curettes
      • Punches

Reasons to subscribe to U.S. biopsy devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. biopsy devices market databook

  • Our clientele includes a mix of biopsy devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. biopsy devices market, including forecasts for subscribers. This country databook contains high-level insights into U.S. biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. biopsy devices market size, by product, 2018-2030 (US$M)

U.S. Biopsy Devices Market Share, 2023 & 2030 (US$M)

U.S. biopsy devices market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more